IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis
Top Cited Papers
Open Access
- 30 October 2006
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 203 (12), 2577-2587
- https://doi.org/10.1084/jem.20060244
Abstract
Aberrant cytokine expression has been proposed as an underlying cause of psoriasis, although it is unclear which cytokines play critical roles. Interleukin (IL)Keywords
This publication has 54 references indexed in Scilit:
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Plasmacytoid predendritic cells initiate psoriasis through interferon-α productionThe Journal of Experimental Medicine, 2005
- PsoriasisNew England Journal of Medicine, 2005
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationThe Journal of Experimental Medicine, 2005
- Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and ‘Type 1’ inflammatory gene expressionTrends in Immunology, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Critical Role of Neutrophils for the Generation of Psoriasiform Skin Lesions in Flaky Skin MiceJournal of Investigative Dermatology, 2000
- Cutaneous rat wounds expressC49a, a novel gene with homology to the human melanoma differentiation associated gene,Mda-7Journal of Cellular Biochemistry, 1999
- Disease concomitance in psoriasisJournal of the American Academy of Dermatology, 1995
- Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical SamplesImmunological Reviews, 1992